Is abciximab an antiplatelet? Understanding its mechanism, uses, and discontinuation
•
4 min read
Yes, abciximab is a potent antiplatelet medication, specifically a glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitor, that was used to prevent blood clots during cardiac procedures. It worked by blocking the final common pathway of platelet aggregation, preventing platelets from sticking together.
